Eli Lilly And Company

This study aims to monitor the long-term safety of the drug pirtobrutinib in people with a type of blood cancer called chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is open only to 150 people who have already completed a specific earlier trial of this…

This study is testing several new potential treatments for adults with moderate to severe ulcerative colitis or Crohn's disease. Participants will be assigned to one of several treatment groups to see if these new options work better than current treatments. The study will last a…

This is the first study in people testing a new drug called LY4584180 for adults with certain blood cancers that have come back or stopped responding to previous treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs tha…

This is an early-stage study to test the safety and effects of a new injectable drug called brenipatide in healthy adults who are overweight or have obesity. Researchers will give different doses to about 150 participants to see how the body handles the drug and if it helps reduc…

This study is testing an oral pill called LY4268989 to see if it can help control symptoms and reduce inflammation in adults with moderate to severe ulcerative colitis. It will compare the pill to a placebo (a dummy pill) in about 1,400 participants over roughly two years. The go…

This study is testing a new breast cancer medication called imlunestrant in premenopausal women with early-stage, hormone-sensitive breast cancer. Researchers will compare how it affects cancer cells and ovaries to the standard drug tamoxifen. The trial includes two groups: one r…

This study is testing whether adding a new drug called LY4395089 to an existing Crohn's disease medication (mirikizumab) works better than the existing medication alone. The trial will involve 60 adults with moderate to severe Crohn's disease and will last about 62 weeks. Researc…

This study is testing whether adding a new drug called brenipatide to standard depression medication can help prevent symptoms from coming back. It will involve about 1,000 adults with major depressive disorder who are already on stable treatment. Participants will receive either…

This early-stage trial is testing a new drug called LY4152199 in people with B-cell lymphomas that have returned or didn't respond to previous treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping control the cancer. The study will enro…

This study aims to check how safe and effective the medication tirzepatide is for adults in India who have type 2 diabetes or who are overweight/obese. About 344 participants will receive the medication for 46 weeks. Researchers will monitor side effects, weight changes, and bloo…

This study is testing whether adding an investigational drug called brenipatide to standard schizophrenia medication is safe and more effective than standard care alone. It will involve 450 adults with schizophrenia who are already on stable medication. The main goal is to see if…

This study is testing a new AI-powered eye scan to see if it can detect early signs of Alzheimer's disease in people with mild memory problems. Researchers will compare the scan results to a blood test in 200 adults from the United Arab Emirates. The goal is to see if this quick,…

This early-stage study aims to compare how the body processes an experimental drug called mirikizumab when given as one injection versus two injections under the skin. It will involve 450 healthy volunteers to check the safety and how the drug moves through the body. The main goa…